SlideShare a Scribd company logo
Rabies virus
Dr. Sshrutkirti Gupta
Rabiesvirus
Family-Rhabdoviridae- (Rhabdos-rod)
2 genera-Lyssavirus,vesiculovirus
Lyssavirus- (Lyssa- madness) Rabiesvirus,
Lagosbat, Makola,Duvenhage,kotankan,
Obodhiang
Vesiculovirus- Chandipura
Morphology
•Shape- Bullet shaped, one end round other end
concave or planer
Knob like surface projections all over the surface
except on concave end
Below the envelop has matrix (M) protein layer –
may project out as bleb from concave end
•Size- length varies
•Enveloped RNA Virus
• Genome –SSRNA-unsegmented-
• Codes for 5 proteins-
• Glycoprotein (G),
• Nucleocapsid (N),
• Viral polymerase (L),
• Two smaller nonstructural proteins (NS)
(P)-MW 38000 & (M)-MW 28000
Peplomer/spike- Present on surface,
Glycoprotein in nature,9 nm long
Haemagglutinating Property- optimal with goose
cells at 0-40cpH 6.2
Nucleocapsid-165x50nm,30-35 coils
Resistance-
highly resistant against dryness, cold
Infective for many wks in cadaver.
Sensitive to lipid solvent-chloroform, acetone,
ether. Ethanol, iodine,soap,phenol,formalin,beta
propiolactone, sunlight, UV
• Street virus- isolated from natural human/
animal infection
• Produce fatal encephalitis- after long
incubation period1-12days
• Produced Negri bodies
• Fixed virus- obtained by several intracerebral
passage in rabbits
• More neurotropic- short incubation period
• Negri bodies usually not demonstrated
Pathogenesis
Highly neurotropic
•Attachment of virus to host cell after inoculation
Via glycoprotein spike
Site of attachment- nicotinic acetylcholine binding
site of plasma mem. of muscle
cell (myotubule)
•Enters peripheral nerve
(time required depends upon conc. &site of bite)
After sufficient multiplication cross myoneural
junction- entry in CNS
(through myelinated sensory and motor axon
terminal)
•Once enter CNS infection cannot be halted by
vaccination
Passage to CNS occurs axonally through
axoplasmic flow (12-24mm/day)until it reaches
next neuron at the level of spinal cord
•First symptom appears when virus multiplies in
spinal ganglion- paresthesis or pain
•Rapid dissemination of virus in CNS(200-400mm/day)
•(Initially cell- cell transfer of bare nucleocapsid
•Later free passage of virus in intracellular space)
•Development of progressive encephalitis
•Centrifugal spread of virus along peripheral
nerve throughout the body – most notably
salivary gland
Clinical features
Incubation period- 20 days to 3yrs.mean (1-3mo)
Route of entry- bite of rabid animal- dog
(Inhalation of virus aerosols generated in bat
caves,rarely through scratch)
Four stages- prodromal, acute neurologic , coma,
complication, death
Prodromal- Usually nonspecific symptoms-
malaise, fever chills, nausea, vomiting
diarrhea, headache, anxiety,
apprehension, irritability.(lasts for 2-10days)
Acute neurologic phase-
Two forms- 1. furious encephalitis (>80%)
2. paralytic (dumb) form (20%)
Furious encephalitis- Hyperactivity, disorientation,
hallucination or bizarre behavior. Hyperactivity
becomes intermittent. Signs of autonomic
instability-often prominent (hyperthermia, tachycardia,
hypertension) Hydrophobia- Attempt of drinking
follows severe spasm of pharynx, larynx.
Aerophobia-due to exaggerated respiratory
irritant reflexes
•Fever, muscle fasciculation, hyperventilation, focal convulsion
Paralytic (dumb) rabies- initially patient is
mentally intact. No hyperactivity as in furious type
Fever, headache frequently present
Paralysis- maximal at bitten extremity,may be
diffuse& symmetric or may be ascending type
neck stiffness
Mental condition gradually deteriorate from
confusion to disorientation, stupor & finally coma
•Last for 2-7 days
•Abrupt death due to respiratory or cardiac arrest
Coma- develops in about 10 days after onset of
symptoms
Lasts for few hours to month
Complications- Neurologic, Pitutary, Pulmonary
Cardiovascular, other
Death due to respiratory or cardiac failure
Laboratory diagnosis
Specimens-
Antimortem- Saliva, CSF, Corneal impression
smear, biopsy from neck( above
hair line) , facial skin biopsy
Postmortem- CSF, brain biopsy.
1.Isolation of virus-
a. intracerebral inoculation in the mice
observe brain tissue for inclusion bodies on
28th day
b. Tissue culture- cell lines used-WI 38, BHK21 --
detection of virus by immunofluorescence-
Results available in 2-4days
2. Demonstration of viral antigen-
By immunofluorescence
3. Detection of inclusion bodies-(Negri bodies)
Intracytoplasmic, oval/ round, purple-pink
characteristic basophilic inner grannules
Size- 3-27 mm, eosinophilic
Stain- Seller’s technique, immunofluorescence
Common- hippocampus, horns of Ammon
Purkingie’s cells of cerebellum
20% of absent
Demonstration of Antibodies
Neutralising antibodies- high titre- in CSF
appear around 6th day
2- 25 times more than serum titre
Detection of Nucleic acid- RT PCR
Prophylaxis-
Preexposure- lab workers
Post exposure- local treatment, vaccination,
hyperimmune sera
Local treatment- soap and water.
Treatment with cetavalon- quaternary ammonium
compound,tincture iodine, alcohol
In severe wound- antirabic serum –infiltrated
around the wound. Excision of damaged tissue
Anti-titanus& antibiotics
Vaccines- 2 types
Neural-
1.semple vaccine- 5% suspension of infected brain.
Inactivated by 5%Phenol
2.Beta propiolactone vaccine(BPL)- 5%
Suspension of infected brain inactivation by BPL –
mainly Indian manufacturing
3.Infant brain vaccine- sucking mice brain.Inactivation
by UV radiation, BPL or phenol
Vaccination Schedule
Semple vaccine BPL vaccine
Class I 2ml x 7days 2ml x 7days
Class II 5ml x 14 days 3ml x 10days
Class III 10ml x 14 days 5ml x 10days
Booster required for BPL vaccine for Class II& III
Class II- 1 dose 3wks after last 10th injection
ClassIII- 2 doses- 1 7days after 10th injection 2nd 2wks
after 1st booster
Non-neural-
1.Duck egg vaccine- discontinued
2.Tissue culture- fixed virus grown in HDCS,WI-38,
MRC-5Inactivation by BPL-no side
effect, highly antigenic
3. Chick embryo vaccine
a.Low egg passage- 40-50 passages- live attenuated-
use for dogs
b.High egg passage- about 180 passages- live
attenuated-use for cattle, cat
Subunit vaccine- Surface glycoprotein G – cloned-
recombinant- under trial.
cell culture Vaccine schedule
•Same for children and adult
•Same for all three available vaccines
•Pre-exposure-
•Three doses- 0,7,21 dose-1ml Route- IM
•Booster after 1 yr & then every 5 yr.
Post exposure prophylaxis
• Local treatment of wound
• Passive immunization-Hyperimmune sera
• Active immunization- vaccination
• Cell culture vaccine- 1.oml- IM- adult- deltoid
• Children-anteriolateral aspect of thigh
• Five doses-
• 0,3,7,14,30 optional 90- protective for 5 yrs- during
this period 1or2 doses required on further exposure
Passive immunisation- Hyperimmune serum
1.Human antirabies immunoglobulin- (HRIG)
20 IU/kg body wt- half dose is infiltrated
locally in wound and other half administered- IM
•Should not be given to individual who had prior
active immunization
2.Equine/ horse hyperimmune serum-(ERIG)
40 IU /kg body wt
risk of hypersensitivity

More Related Content

Similar to Rabiesvirus.ppt

Rabies Powerpoint Presentation aerophobia, dog bite prophylaxis, hydrophobia,...
Rabies Powerpoint Presentation aerophobia, dog bite prophylaxis, hydrophobia,...Rabies Powerpoint Presentation aerophobia, dog bite prophylaxis, hydrophobia,...
Rabies Powerpoint Presentation aerophobia, dog bite prophylaxis, hydrophobia,...
Dr Sujith Chadala
 
Rhabdovirus lecture
Rhabdovirus lectureRhabdovirus lecture
Rhabdovirus lecture
deepak deshkar
 
Rabies copy
Rabies   copyRabies   copy
Rabies copy
LivyaJivin
 
Rhabdo Viruses (Rabies virus)
Rhabdo Viruses (Rabies virus)Rhabdo Viruses (Rabies virus)
Rhabdo Viruses (Rabies virus)
Alok Kumar
 
Rabies
RabiesRabies
Poliomylitis.pptx
Poliomylitis.pptxPoliomylitis.pptx
Poliomylitis.pptx
ZaighamAbbas48
 
Rabies.pptx
Rabies.pptxRabies.pptx
Rabies.pptx
Divija Ramachandran
 
Rhabdoviridae.
Rhabdoviridae.Rhabdoviridae.
Rhabdoviridae.
ssuserf581fb
 
Rabies
RabiesRabies
Rabies
David Orji
 
RABIES (RHABDOVIRUS)
RABIES (RHABDOVIRUS)RABIES (RHABDOVIRUS)
RABIES (RHABDOVIRUS)
Suraj Dhara
 
Japanese encephalitis
Japanese encephalitisJapanese encephalitis
Japanese encephalitis
Ubaid N P
 
Rabies a quick look at the disease...ppt2.ppt
Rabies a quick look at the disease...ppt2.pptRabies a quick look at the disease...ppt2.ppt
Rabies a quick look at the disease...ppt2.ppt
MwambaChikonde1
 
Rabies
Rabies Rabies
POWER POINT PRESENETAION REGARDING LARGE ANIMAL
POWER POINT PRESENETAION REGARDING LARGE ANIMALPOWER POINT PRESENETAION REGARDING LARGE ANIMAL
POWER POINT PRESENETAION REGARDING LARGE ANIMAL
MadhudarshiKumar2
 
Rabies
RabiesRabies
Rabies
soumyasil
 
Lecture 3 : Animal Diseases for Veterinary Science
Lecture 3 : Animal Diseases for Veterinary ScienceLecture 3 : Animal Diseases for Veterinary Science
Lecture 3 : Animal Diseases for Veterinary Science
WiseAcademy
 
Micro bio(rhebovirus)
Micro bio(rhebovirus)Micro bio(rhebovirus)
Micro bio(rhebovirus)
Viju Rathod
 

Similar to Rabiesvirus.ppt (20)

Rabies Powerpoint Presentation aerophobia, dog bite prophylaxis, hydrophobia,...
Rabies Powerpoint Presentation aerophobia, dog bite prophylaxis, hydrophobia,...Rabies Powerpoint Presentation aerophobia, dog bite prophylaxis, hydrophobia,...
Rabies Powerpoint Presentation aerophobia, dog bite prophylaxis, hydrophobia,...
 
Rhabdovirus lecture
Rhabdovirus lectureRhabdovirus lecture
Rhabdovirus lecture
 
Rabies copy
Rabies   copyRabies   copy
Rabies copy
 
Rhabdo Viruses (Rabies virus)
Rhabdo Viruses (Rabies virus)Rhabdo Viruses (Rabies virus)
Rhabdo Viruses (Rabies virus)
 
Rabies
RabiesRabies
Rabies
 
Poliomylitis.pptx
Poliomylitis.pptxPoliomylitis.pptx
Poliomylitis.pptx
 
Rabies.pptx
Rabies.pptxRabies.pptx
Rabies.pptx
 
Rhabdoviridae.
Rhabdoviridae.Rhabdoviridae.
Rhabdoviridae.
 
Rabies
RabiesRabies
Rabies
 
RABIES (RHABDOVIRUS)
RABIES (RHABDOVIRUS)RABIES (RHABDOVIRUS)
RABIES (RHABDOVIRUS)
 
Japanese encephalitis
Japanese encephalitisJapanese encephalitis
Japanese encephalitis
 
Rabies
RabiesRabies
Rabies
 
Rabies a quick look at the disease...ppt2.ppt
Rabies a quick look at the disease...ppt2.pptRabies a quick look at the disease...ppt2.ppt
Rabies a quick look at the disease...ppt2.ppt
 
Rabies
Rabies Rabies
Rabies
 
POWER POINT PRESENETAION REGARDING LARGE ANIMAL
POWER POINT PRESENETAION REGARDING LARGE ANIMALPOWER POINT PRESENETAION REGARDING LARGE ANIMAL
POWER POINT PRESENETAION REGARDING LARGE ANIMAL
 
Animal And Insect Bites
Animal And Insect BitesAnimal And Insect Bites
Animal And Insect Bites
 
Rabies
RabiesRabies
Rabies
 
Rabies
RabiesRabies
Rabies
 
Lecture 3 : Animal Diseases for Veterinary Science
Lecture 3 : Animal Diseases for Veterinary ScienceLecture 3 : Animal Diseases for Veterinary Science
Lecture 3 : Animal Diseases for Veterinary Science
 
Micro bio(rhebovirus)
Micro bio(rhebovirus)Micro bio(rhebovirus)
Micro bio(rhebovirus)
 

More from Shrutkirtigupta1

viral diarrhoea.ppt
viral diarrhoea.pptviral diarrhoea.ppt
viral diarrhoea.ppt
Shrutkirtigupta1
 
Miscellaneous Infectious.pptx
Miscellaneous Infectious.pptxMiscellaneous Infectious.pptx
Miscellaneous Infectious.pptx
Shrutkirtigupta1
 
Biomedical Waste Management.pptx
Biomedical Waste Management.pptxBiomedical Waste Management.pptx
Biomedical Waste Management.pptx
Shrutkirtigupta1
 
Biofilms.pdf
Biofilms.pdfBiofilms.pdf
Biofilms.pdf
Shrutkirtigupta1
 
filariasis.pptx
filariasis.pptxfilariasis.pptx
filariasis.pptx
Shrutkirtigupta1
 
Lab diagnosis-viruses.ppt
Lab diagnosis-viruses.pptLab diagnosis-viruses.ppt
Lab diagnosis-viruses.ppt
Shrutkirtigupta1
 
sterlisation part 1.pptx
sterlisation part 1.pptxsterlisation part 1.pptx
sterlisation part 1.pptx
Shrutkirtigupta1
 
STAINING TECHNIQUES.pptx
STAINING TECHNIQUES.pptxSTAINING TECHNIQUES.pptx
STAINING TECHNIQUES.pptx
Shrutkirtigupta1
 
(POLYREACTIVE ANTIBODIES IN HEALTH AND DISEASE).pptx
(POLYREACTIVE ANTIBODIES IN HEALTH AND DISEASE).pptx(POLYREACTIVE ANTIBODIES IN HEALTH AND DISEASE).pptx
(POLYREACTIVE ANTIBODIES IN HEALTH AND DISEASE).pptx
Shrutkirtigupta1
 
clostridium.pptx
clostridium.pptxclostridium.pptx
clostridium.pptx
Shrutkirtigupta1
 
Mycetoma.pptx
Mycetoma.pptxMycetoma.pptx
Mycetoma.pptx
Shrutkirtigupta1
 
Antibody.pptx
Antibody.pptxAntibody.pptx
Antibody.pptx
Shrutkirtigupta1
 
AFST .pptx
AFST .pptxAFST .pptx
AFST .pptx
Shrutkirtigupta1
 
Adult immunisation.pptx
Adult immunisation.pptxAdult immunisation.pptx
Adult immunisation.pptx
Shrutkirtigupta1
 
CULTURE MEDIA & CULTURE METHODS.ppt
CULTURE  MEDIA & CULTURE METHODS.pptCULTURE  MEDIA & CULTURE METHODS.ppt
CULTURE MEDIA & CULTURE METHODS.ppt
Shrutkirtigupta1
 

More from Shrutkirtigupta1 (20)

viral diarrhoea.ppt
viral diarrhoea.pptviral diarrhoea.ppt
viral diarrhoea.ppt
 
Miscellaneous Infectious.pptx
Miscellaneous Infectious.pptxMiscellaneous Infectious.pptx
Miscellaneous Infectious.pptx
 
Biomedical Waste Management.pptx
Biomedical Waste Management.pptxBiomedical Waste Management.pptx
Biomedical Waste Management.pptx
 
Biofilms.pdf
Biofilms.pdfBiofilms.pdf
Biofilms.pdf
 
filariasis.pptx
filariasis.pptxfilariasis.pptx
filariasis.pptx
 
Lab diagnosis-viruses.ppt
Lab diagnosis-viruses.pptLab diagnosis-viruses.ppt
Lab diagnosis-viruses.ppt
 
sterlisation part 1.pptx
sterlisation part 1.pptxsterlisation part 1.pptx
sterlisation part 1.pptx
 
STAINING TECHNIQUES.pptx
STAINING TECHNIQUES.pptxSTAINING TECHNIQUES.pptx
STAINING TECHNIQUES.pptx
 
new crbsi.ppt
new crbsi.pptnew crbsi.ppt
new crbsi.ppt
 
Human Brucellosis.pptx
Human  Brucellosis.pptxHuman  Brucellosis.pptx
Human Brucellosis.pptx
 
CRBSI.ppt
CRBSI.pptCRBSI.ppt
CRBSI.ppt
 
VAP.pptx
VAP.pptxVAP.pptx
VAP.pptx
 
(POLYREACTIVE ANTIBODIES IN HEALTH AND DISEASE).pptx
(POLYREACTIVE ANTIBODIES IN HEALTH AND DISEASE).pptx(POLYREACTIVE ANTIBODIES IN HEALTH AND DISEASE).pptx
(POLYREACTIVE ANTIBODIES IN HEALTH AND DISEASE).pptx
 
clostridium.pptx
clostridium.pptxclostridium.pptx
clostridium.pptx
 
Mycetoma.pptx
Mycetoma.pptxMycetoma.pptx
Mycetoma.pptx
 
Antibody.pptx
Antibody.pptxAntibody.pptx
Antibody.pptx
 
AFST .pptx
AFST .pptxAFST .pptx
AFST .pptx
 
Adult immunisation.pptx
Adult immunisation.pptxAdult immunisation.pptx
Adult immunisation.pptx
 
CULTURE MEDIA & CULTURE METHODS.ppt
CULTURE  MEDIA & CULTURE METHODS.pptCULTURE  MEDIA & CULTURE METHODS.ppt
CULTURE MEDIA & CULTURE METHODS.ppt
 
Autoimmunity.ppt
Autoimmunity.pptAutoimmunity.ppt
Autoimmunity.ppt
 

Recently uploaded

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
Dr. Rabia Inam Gandapore
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 

Recently uploaded (20)

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 

Rabiesvirus.ppt

  • 2. Rabiesvirus Family-Rhabdoviridae- (Rhabdos-rod) 2 genera-Lyssavirus,vesiculovirus Lyssavirus- (Lyssa- madness) Rabiesvirus, Lagosbat, Makola,Duvenhage,kotankan, Obodhiang Vesiculovirus- Chandipura
  • 3. Morphology •Shape- Bullet shaped, one end round other end concave or planer Knob like surface projections all over the surface except on concave end Below the envelop has matrix (M) protein layer – may project out as bleb from concave end •Size- length varies •Enveloped RNA Virus
  • 4. • Genome –SSRNA-unsegmented- • Codes for 5 proteins- • Glycoprotein (G), • Nucleocapsid (N), • Viral polymerase (L), • Two smaller nonstructural proteins (NS) (P)-MW 38000 & (M)-MW 28000
  • 5. Peplomer/spike- Present on surface, Glycoprotein in nature,9 nm long Haemagglutinating Property- optimal with goose cells at 0-40cpH 6.2 Nucleocapsid-165x50nm,30-35 coils
  • 6.
  • 7. Resistance- highly resistant against dryness, cold Infective for many wks in cadaver. Sensitive to lipid solvent-chloroform, acetone, ether. Ethanol, iodine,soap,phenol,formalin,beta propiolactone, sunlight, UV
  • 8.
  • 9. • Street virus- isolated from natural human/ animal infection • Produce fatal encephalitis- after long incubation period1-12days • Produced Negri bodies • Fixed virus- obtained by several intracerebral passage in rabbits • More neurotropic- short incubation period • Negri bodies usually not demonstrated
  • 10. Pathogenesis Highly neurotropic •Attachment of virus to host cell after inoculation Via glycoprotein spike Site of attachment- nicotinic acetylcholine binding site of plasma mem. of muscle cell (myotubule) •Enters peripheral nerve (time required depends upon conc. &site of bite)
  • 11. After sufficient multiplication cross myoneural junction- entry in CNS (through myelinated sensory and motor axon terminal) •Once enter CNS infection cannot be halted by vaccination Passage to CNS occurs axonally through axoplasmic flow (12-24mm/day)until it reaches next neuron at the level of spinal cord
  • 12. •First symptom appears when virus multiplies in spinal ganglion- paresthesis or pain •Rapid dissemination of virus in CNS(200-400mm/day) •(Initially cell- cell transfer of bare nucleocapsid •Later free passage of virus in intracellular space) •Development of progressive encephalitis •Centrifugal spread of virus along peripheral nerve throughout the body – most notably salivary gland
  • 13. Clinical features Incubation period- 20 days to 3yrs.mean (1-3mo) Route of entry- bite of rabid animal- dog (Inhalation of virus aerosols generated in bat caves,rarely through scratch) Four stages- prodromal, acute neurologic , coma, complication, death Prodromal- Usually nonspecific symptoms- malaise, fever chills, nausea, vomiting diarrhea, headache, anxiety, apprehension, irritability.(lasts for 2-10days)
  • 14. Acute neurologic phase- Two forms- 1. furious encephalitis (>80%) 2. paralytic (dumb) form (20%) Furious encephalitis- Hyperactivity, disorientation, hallucination or bizarre behavior. Hyperactivity becomes intermittent. Signs of autonomic instability-often prominent (hyperthermia, tachycardia, hypertension) Hydrophobia- Attempt of drinking follows severe spasm of pharynx, larynx. Aerophobia-due to exaggerated respiratory irritant reflexes •Fever, muscle fasciculation, hyperventilation, focal convulsion
  • 15. Paralytic (dumb) rabies- initially patient is mentally intact. No hyperactivity as in furious type Fever, headache frequently present Paralysis- maximal at bitten extremity,may be diffuse& symmetric or may be ascending type neck stiffness Mental condition gradually deteriorate from confusion to disorientation, stupor & finally coma •Last for 2-7 days •Abrupt death due to respiratory or cardiac arrest
  • 16. Coma- develops in about 10 days after onset of symptoms Lasts for few hours to month Complications- Neurologic, Pitutary, Pulmonary Cardiovascular, other Death due to respiratory or cardiac failure
  • 17. Laboratory diagnosis Specimens- Antimortem- Saliva, CSF, Corneal impression smear, biopsy from neck( above hair line) , facial skin biopsy Postmortem- CSF, brain biopsy. 1.Isolation of virus- a. intracerebral inoculation in the mice observe brain tissue for inclusion bodies on 28th day
  • 18. b. Tissue culture- cell lines used-WI 38, BHK21 -- detection of virus by immunofluorescence- Results available in 2-4days 2. Demonstration of viral antigen- By immunofluorescence 3. Detection of inclusion bodies-(Negri bodies) Intracytoplasmic, oval/ round, purple-pink characteristic basophilic inner grannules Size- 3-27 mm, eosinophilic Stain- Seller’s technique, immunofluorescence
  • 19. Common- hippocampus, horns of Ammon Purkingie’s cells of cerebellum 20% of absent Demonstration of Antibodies Neutralising antibodies- high titre- in CSF appear around 6th day 2- 25 times more than serum titre Detection of Nucleic acid- RT PCR
  • 20. Prophylaxis- Preexposure- lab workers Post exposure- local treatment, vaccination, hyperimmune sera Local treatment- soap and water. Treatment with cetavalon- quaternary ammonium compound,tincture iodine, alcohol In severe wound- antirabic serum –infiltrated around the wound. Excision of damaged tissue Anti-titanus& antibiotics
  • 21. Vaccines- 2 types Neural- 1.semple vaccine- 5% suspension of infected brain. Inactivated by 5%Phenol 2.Beta propiolactone vaccine(BPL)- 5% Suspension of infected brain inactivation by BPL – mainly Indian manufacturing 3.Infant brain vaccine- sucking mice brain.Inactivation by UV radiation, BPL or phenol
  • 22. Vaccination Schedule Semple vaccine BPL vaccine Class I 2ml x 7days 2ml x 7days Class II 5ml x 14 days 3ml x 10days Class III 10ml x 14 days 5ml x 10days Booster required for BPL vaccine for Class II& III Class II- 1 dose 3wks after last 10th injection ClassIII- 2 doses- 1 7days after 10th injection 2nd 2wks after 1st booster
  • 23. Non-neural- 1.Duck egg vaccine- discontinued 2.Tissue culture- fixed virus grown in HDCS,WI-38, MRC-5Inactivation by BPL-no side effect, highly antigenic 3. Chick embryo vaccine a.Low egg passage- 40-50 passages- live attenuated- use for dogs b.High egg passage- about 180 passages- live attenuated-use for cattle, cat Subunit vaccine- Surface glycoprotein G – cloned- recombinant- under trial.
  • 24. cell culture Vaccine schedule •Same for children and adult •Same for all three available vaccines •Pre-exposure- •Three doses- 0,7,21 dose-1ml Route- IM •Booster after 1 yr & then every 5 yr.
  • 25. Post exposure prophylaxis • Local treatment of wound • Passive immunization-Hyperimmune sera • Active immunization- vaccination • Cell culture vaccine- 1.oml- IM- adult- deltoid • Children-anteriolateral aspect of thigh • Five doses- • 0,3,7,14,30 optional 90- protective for 5 yrs- during this period 1or2 doses required on further exposure
  • 26. Passive immunisation- Hyperimmune serum 1.Human antirabies immunoglobulin- (HRIG) 20 IU/kg body wt- half dose is infiltrated locally in wound and other half administered- IM •Should not be given to individual who had prior active immunization 2.Equine/ horse hyperimmune serum-(ERIG) 40 IU /kg body wt risk of hypersensitivity